It is a business services public limited company based in New Delhi, Delhi, India, established in 1995.
1995 | New Delhi, Delhi, India | AmalgamatedSolus Pharmaceuticals Limited, a amalgamated public limited company, was established on 24 February 1995 in New Delhi, Delhi, India. it holds CIN: U74899DL1995PLC065783. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹14.90 Cr.
Its leadership includes Sanjeev Indravadan Dani (Director), Ashwani Kumar Malhotra (Nominee Director), Ranjit Kohli (Director). Past directors included Ashwani Kumar Malhotra, Ramesh Kumar Parekh, Ranjit Kohli. Its latest AGM occurred on 10 May 2012, with the balance sheet filed on 31 December 2011. It is based at 12Th Floor Devika Towernehru Tower Nehru Place, New Delhi, Delhi, 110019.
U74899DL1995PLC065783
065783
24 February 1995
₹15.00 Cr
₹14.90 Cr
Roc Delhi
Unlisted
Amalgamated
Explore comprehensive insights into Solus Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjeev Indravadan Dani | Director | 28 Jul 2005 | Current |
| Ashwani Kumar Malhotra | Nominee Director | 01 Nov 2010 | Current |
| Ranjit Kohli | Director | 12 Mar 2012 | Current |
| Sandeep Mehandroo | Director | 30 Jan 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 10 May 2011 | Past |
| Pramod Abcsdd | Director | 18 Oct 2010 | Past |
| Pramod Abcsdd | Additional Director | 10 May 2012 | Past |
| Pramod Abcsdd | Director Appointed In Casual Vacancy | 28 May 2009 | Past |
| Pramod Abcsdd | Director | 18 Oct 2010 | Past |
| Pramod Abcsdd | Additional Director | 10 May 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Solus Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Solus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Solus Pharmaceuticals has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Solus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Solus Pharmaceuticals Limited last Annual general meeting of members was held on 10 May 2012 as per latest MCA records. was recorded as a recent event.
Progress on Ranjit Kohli was appointed as a Director was appointed as a Director on 12 Mar 2012 & has been associated with this company since 13 years 8 months . was documented.
Solus Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Dec 2011 with Roc Delhi. was recorded as a recent event.
The activity Ashwani Kumar Malhotra was appointed as a Nominee Director was appointed as a Nominee Director on 01 Nov 2010 & has been associated with this company since 15 years 29 days . was completed.
Sandeep Mehandroo was appointed as a Director was appointed as a Director on 30 Jan 2008 & has been associated with this company since 17 years 10 months . was recorded as a recent event.
The activity Sanjeev Indravadan Dani was appointed as a Director was appointed as a Director on 28 Jul 2005 & has been associated with this company since 20 years 4 months . was completed.
The CIN of Solus Pharmaceuticals Limited is U74899DL1995PLC065783.
Solus Pharmaceuticals Limited is headquartered at 12Th Floor Devika Towernehru Tower Nehru Place, New Delhi, Delhi, 110019.
Solus Pharmaceuticals Limited was incorporated on 24 February 1995.
The current directors of Solus Pharmaceuticals Limited are
Solus Pharmaceuticals Limited is unlisted.
The authorized capital of Solus Pharmaceuticals Limited is ₹15.00 Cr, and the paid-up capital is ₹14.90 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX